Jared M. Baeten

2001–2025 年に発表

238
論文数
25,661
被引用数
88
h 指数
232
i10 指数

被引用数

Jared M. Baeten の年別被引用数1986 年: 被引用 1 件1988 年: 被引用 4 件2002 年: 被引用 2 件2003 年: 被引用 6 件2004 年: 被引用 7 件2005 年: 被引用 12 件2006 年: 被引用 18 件2007 年: 被引用 33 件2008 年: 被引用 40 件2009 年: 被引用 50 件2010 年: 被引用 72 件2011 年: 被引用 144 件2012 年: 被引用 167 件2013 年: 被引用 194 件2014 年: 被引用 236 件2015 年: 被引用 219 件2016 年: 被引用 230 件2017 年: 被引用 171 件2018 年: 被引用 178 件2019 年: 被引用 839 件2020 年: 被引用 855 件2021 年: 被引用 908 件2022 年: 被引用 747 件2023 年: 被引用 632 件2024 年: 被引用 991 件2025 年: 被引用 479 件2026 年: 被引用 7 件1987 年は被引用が無いため表示していません1989〜2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,703 件、この内訳の 31.8%南アフリカ: 引用元論文 757 件、この内訳の 8.9%イギリス: 引用元論文 716 件、この内訳の 8.4%ケニア: 引用元論文 404 件、この内訳の 4.7%カナダ: 引用元論文 317 件、この内訳の 3.7%ウガンダ: 引用元論文 287 件、この内訳の 3.4%スイス: 引用元論文 230 件、この内訳の 2.7%オーストラリア: 引用元論文 214 件、この内訳の 2.5%中国: 引用元論文 192 件、この内訳の 2.3%フランス: 引用元論文 166 件、この内訳の 2%オランダ: 引用元論文 165 件、この内訳の 1.9%ジンバブエ: 引用元論文 136 件、この内訳の 1.6%
0%31.8%その他 26.1%

分野

  • Medicine65%
  • Immunology and Microbiology22.2%
  • Health Professions3.5%
  • Social Sciences3.3%
  • Biochemistry, Genetics and Molecular Biology2.3%
  • Psychology0.7%
  • その他3%

トピック

  • HIV/AIDS Research and Interventions20.1%
  • Adolescent Sexual and Reproductive Health8%
  • HIV Research and Treatment7.9%
  • HIV, Drug Use, Sexual Risk7.2%
  • Reproductive tract infections research6.4%
  • HIV/AIDS drug development and treatment5.8%
  • その他44.6%

共著者

全論文

検索で開く
  1. Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth Spooner, Amy Ward, Zwelethu Zwane, Ramin Ebrahimi, Yang Zhao, Alexander Kintu, Chris Deaton, Christoph C Carter, Jared M. Baeten, Flavia Matovu Kiweewa - New England Journal of Medicine 2024 被引用: 427

  2. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meighan Krows, Jennifer Revall, Susan Morrison, Harald S. Haugen, Mira Emmanuel-Ogier, Lisa Ondrejcek, Robert W. Coombs, Lisa M. Frenkel, Craig W. Hendrix, Namandjé N. Bumpus, David R. Bangsberg, Jessica E. Haberer, Wendy Stevens, Jairam R. Lingappa, Connie Celum - New England Journal of Medicine 2012 被引用: 3,309

  3. Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection

    著者: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 被引用: 297

  4. Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , - NEJM Evidence 2022 被引用: 206

  5. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashley Mayo, Rachel Scheckter, Jennifer Berthiaume, Edward Livant, Cindy Jacobson, Patrick Ndase, Rhonda White, Karen Patterson, Donna Germuga, Beth Galaska, Katherine Bunge, Devika Singh, Daniel Szydlo, Elizabeth Montgomery, Barbara Mensch, Kristine Torjesen, Cynthia I. Grossman, Nahida Chakhtoura, Annaléne Nel, Zeda Rosenberg, Ian McGowan, Sharon L. Hillier - New England Journal of Medicine 2016 被引用: 764

  6. Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial

    著者: , , , , , , , , , , , , , , , - The Lancet HIV 2022 被引用: 102

  7. Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Ondrejcek, G.W. Robertson, Angela Williams, Elizabeth R. Brown, Jody Carter, Denise A. Galloway, Leeya F. Pinder, Priya R. Prabhu, Robin A.J. Smith, M. Wright, Stephen O. Abiero, Maqline A. Achola, Meldah O. Adipo, Katherine L. Amukonyi, Cynthia Akinyi, Teresia O. Akinyi, Penina N. Amboka, Karl D. Arum, Veronica O. Atogo, Pius O. Atonga, A.J. ten Cate, Daisy Chepkoros, Oyamo O. Christopher, Imelda N. Imali, Mildred Imbayi, Lizzie N. Kabete, Enericah K. Kanampiu, Geoffrey Kebaso, Dennis Kegode, Timothy Kwena, Reina Lenturkana, Celestine Lihavi, David N. Marwa, Patricia Matti, P. Mboya, Elijah Mbuya, L. Memo, Robai M. Mituyi, Benard M. Muga, David E. Muhoma, Elizabeth L. Musi, Gilbert C. Mutai, Simon M. Muthusi, Ivy M. Mutuiri, Catherine W. Mwakio, Bill Nyongesa, Maureen A. Ochieng, Vincent R. Ochuka, Belder A. Odedo, Esther A. Odeny, Vincent O. Odera, Debora A. Odhiambo, Perez O. Odhiambo, Janet A. Okeyo, Linet A. Okode, Nollyne A. Okuku, Irene Okumu, L A Okumu, Christine A. Olweny, Hellen A. Olweyo, G. Omondi, Donnavane A. Ondego, Florence A. Ondiek, Joan A. Ongere, Maricianah Onono, Kevin Onyango, Annette A. Opondo, Millicent A. Oronje, Beryl A. Osoga, Rebecca A. Otieno ほか 86 名 - Nature Medicine 2023 被引用: 86

  8. Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nkosiphile Ndlovu, Richard Novák, Alma Perez Rios, Nittaya Phanuphak, Moti Ramgopal, Peter Ruane, Jorge Sánchez, Breno Santos, Patric Schine, Tanya Schreibman, LaShonda Spencer, Olivia T. Van Gerwen, Ricardo Vasconcelos, Jose Gabriel Vasquez, Zwelethu Zwane, Stephanie Cox, Chris Deaton, Ramin Ebrahimi, Pamela Wong, Renu Singh, Lillian B. Brown, Christoph C Carter, Moupali Das, Jared M. Baeten, Onyema Ogbuagu - New England Journal of Medicine 2024 被引用: 229

  9. Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women

    著者: , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 111

  10. Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study

    著者: , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2018 被引用: 261

  11. Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Debbie Hagins, Gordon Crofoot, James J. Sims, Olayemi Osiyemi, Theo Hodge, Christine Zurawski, Onyema Ogbuagu, Sorana Segal‐Maurer, Onyema Ogbuagu, Sorana Segal-Maurer, Krittaecho Siripassorn, Ploenchan Chetchotisakd, Antonella Castagna, Andrea Antinori, Francesco Castelli, Sylvie Ronot-Bregigeon, Jean‐Michel Molina, Yazdan Yazdanpanah, Benoît Trottier, Jason Brunetta, Takuma Shirasaka, Yoshiyuki Yokomaku, Ellen Koenig, Josep Mallolas, Hans‐Jürgen Stellbrink, Chien‐Ching Hung, Mohammed Rassool, Chien‐Ching Hung, Mohammed Rassool - The Lancet HIV 2023 被引用: 69

  12. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2021 被引用: 178

  13. Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1: five-year follow-up from two randomized trials

    著者: , , , , , , , , , , , , , , - EClinicalMedicine 2023 被引用: 85

  14. HIV pre‐exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery

    著者: , , , , , , , , - Journal of the International AIDS Society 2019 被引用: 261

  15. Adolescent girls and young women’s PrEP-user journey during an implementation science study in South Africa and Kenya

    著者: , , , , , , , , , , , , , , , - PLoS ONE 2021 被引用: 141

  16. PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of the International AIDS Society 2022 被引用: 93

  17. Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation programme

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline Q Adhiambo, Joel A Otieno, Joseph M Mwendwa, Joyness B Kemunto, Magdalene C Rono, Martin C Ndung'u, Mary I A Osama, Maurine A Odhiambo, Melvin A Kiche, Meridah M Mwania, Neera Bhatt, Osama M Auma, Paskal O Otieno, Pauline Achieng, Peris W Muthoni, Rose K Chiira, Serede M Mmbukane, Sila J Mwania, Steve J Ochieng, Titus Kipyegon, Tonny O Ochieng, Valarie Kemunto, Veronica A Odede, Vivian A Obote, Winnie N Mituga, Yvonne F Fondo - The Lancet HIV 2019 被引用: 169

  18. HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women

    著者: , , , , , , , , , , , , , , , - JAMA 2024 被引用: 74

  19. Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study

    著者: , , , , , , , , , , , , , , , , - The Lancet HIV 2024 被引用: 45

  20. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa

    著者: , , , , , , , - BMC Health Services Research 2021 被引用: 95

  21. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Craig W. Hendrix, Peter L. Anderson, Kenneth Ngure - The Lancet HIV 2023 被引用: 60

  22. Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya

    著者: , , , , , , , , , - PLoS Medicine 2019 被引用: 182

  23. PrEP rollout in Africa: status and opportunity

    著者: , - Nature Medicine 2020 被引用: 132

  24. Defining success with HIV pre-exposure prophylaxis

    著者: , , , , , , , , , , , - AIDS 2015 被引用: 318